載入...
TLR AGONISTS: Are They Good Adjuvants?
Therapeutic immunization leading to cancer regression remains a significant challenge. Successful immunization requires activation of adaptive immunity, including tumor specific CD4 + T cells and CD8+ T cells. Generally speaking, the activation of T cells is compromised in patients with cancer due t...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2922045/ https://ncbi.nlm.nih.gov/pubmed/20693851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e3181eaca65 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|